Search found 469 matches

by velvetmagnetta
Mon 25 May 2015 7:45
Forum: Published Studies
Topic: Differences in Questing Behavior of I. scapularis nymphs
Replies: 1
Views: 540

Re: Differences in Questing Behavior of I. scapularis nymphs

Very interesting. Thanks for posting, Rita!
by velvetmagnetta
Mon 25 May 2015 7:33
Forum: Published Studies
Topic: Publish-Palooza!
Replies: 25
Views: 4459

Re: Publish-Palooza!

From the Marques paper: Many tests for Lyme disease are being performed in patients with low likelihood to have the disease, a situation in which a positive result is more likely to be a false-positive. Whenever I see this statement, I have to wonder, well, how does anyone really know this? If peopl...
by velvetmagnetta
Sun 24 May 2015 19:55
Forum: Published Studies
Topic: Publish-Palooza!
Replies: 25
Views: 4459

Re: Publish-Palooza!

Even the subset of chronically symptomatic patients with a well-documented history of Lyme disease, usually termed PLDS, have little evidence of active infection... Even people with active infection have little evidence of active infection. What, exactly, are we using to measure active infection? I...
by velvetmagnetta
Sat 23 May 2015 18:19
Forum: Published Studies
Topic: Long-term QOL in patients with early LD
Replies: 12
Views: 2124

Re: Long-term QOL in patients with early LD

Approximately 70–80% of patients have EM as the earliest manifestation of Lyme disease. The study by Wormser et al focused on these patients, but did not include patients with extracutaneous manifestations of Lyme disease. Thus, the study did not specifically include (or exclude) patients with neur...
by velvetmagnetta
Fri 22 May 2015 4:48
Forum: Published Studies
Topic: Oral Doxy for Lyme meningo-radiculitis in US
Replies: 9
Views: 2530

Re: Oral Doxy for Lyme meningo-radiculitis in US

This is good news, isn't it? Oral doxycycline is much more convenient, safer and cheaper than intravenous ceftriaxone. The data that I am missing is the dosage. Since it's a case of neuroborreliosis I am guessing 400 mg per day. I agree with you, Martian. IV antibiotics always seemed so risky to me...
by velvetmagnetta
Wed 20 May 2015 9:24
Forum: Published Studies
Topic: Publish-Palooza!
Replies: 25
Views: 4459

Publish-Palooza!

Ooh...A furious publishing flurry ensues from the Infectious Diseases Clinics of North America - The usual old news from the usual old suspects: Hmm...Let's see.. From Halperin Nervous System Lyme Disease http://www.id.theclinics.com/article/S0891-5520%2815%2900016-1/abstract?rss=yes (With the gall ...
by velvetmagnetta
Sat 16 May 2015 16:30
Forum: Published Studies
Topic: Drug Combinations against Borrelia burgdorferi Persisters
Replies: 18
Views: 4583

Re: Drug Combinations against Borrelia burgdorferi Persister

If Dr. Horowitz was wrong, then he was wrong...Just like everybody else in Lyme research history has been wrong. Nobody really knows what to do about persisting symptoms. Hell, the CDC and IDSA are just now admitting that many people in fact have lingering debilitating symptoms after a full course o...
by velvetmagnetta
Sat 16 May 2015 15:49
Forum: Unconventional
Topic: Can glutathione help lyme disease sufferers ?
Replies: 3
Views: 6682

Re: Can glutathione help lyme disease sufferers ?

I don't get it, Martian. Why aren't you thinking highly of Dr Horowitz? Seems to me that he is trying. Trying to help patients. Trying to think up theories and test them out. Is glutathionine a dangerous compound? Or is it benign? Would someone with ALS and two months to live think that trying a sim...
by velvetmagnetta
Mon 11 May 2015 15:10
Forum: Published Studies
Topic: IGeneX changes interpretation criteria for positive serology
Replies: 13
Views: 8153

Re: IGeneX changes interpretation criteria for positive sero

Isn't that why all of Lymeland cheers for the Igenex test? Because they test for two possible strains instead of just one? Now if some enterprising lab would make the leap and create an all-in-one Blot that tests for all Borrelia strains known for each type: burgdorgeri , afzelii, garinii, and even ...